Pupillometer Market Size and Share

Pupillometer Market Summary
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Pupillometer Market Analysis by Mordor Intelligence

The pupillometer market currently stands at USD 453.69 million and is projected to reach USD 648.31 million by 2030, advancing at a 7.40% CAGR. Rapid adoption of quantitative pupillometry in trauma centers and intensive care units is widening clinical acceptance, while the fusion of infrared optics with AI algorithms is shrinking assessment time from minutes to seconds, boosting critical-care responsiveness. Original equipment manufacturers (OEMs) are embedding secure cloud connectivity that streams de-identified pupillary metrics to electronic health records, aiding trend analysis and early neurological intervention. Sports medicine, defense healthcare, and tele-neurology are opening new addressable volumes as portable and smartphone-based devices allow field deployment. Meanwhile, reimbursement ambiguity and clinician training gaps continue to temper near-term uptake despite clear evidence of outcome improvement.

Key Report Takeaways

  • By modality, table-top systems led with 54.74% revenue share in 2024; hand-held devices are forecast to expand at a 7.98% CAGR through 2030. 
  • By type, video technology captured 52.15% of the pupillometer market share in 2024, while digital infrared systems are growing at 8.14% CAGR. 
  • By application, ophthalmology accounted for 60.39% share of the pupillometer market size in 2024; neurology applications are advancing at an 8.47% CAGR to 2030. 
  • By end user, hospitals retained 59.14% share in 2024; eye clinics and vision centers are set to grow at an 8.61% CAGR through 2030. 
  • Regionally, North America dominated with 43.18% share in 2024; Asia-Pacific is the fastest-growing region at an 8.87% CAGR.

Segment Analysis

By Modality: Portability Catalyzes Hand-Held Uptake

Hand-held devices are moving the pupillometer market forward with a 7.98% CAGR as emergency departments and athletic programs favor lightweight designs that run an entire shift on a single charge. Table-top systems still secure 54.74% of 2024 revenue by integrating seamlessly into ICU monitoring arrays, offering multi-parameter analytics alongside vital signs.

Advances in lithium-ion batteries and miniaturized optics are shrinking unit weight below 300 grams, allowing first responders to capture pupillary metrics mid-transport. Table-top platforms increasingly bundle AI dashboards that push alerts to neurologists’ smartphones, retaining relevance despite their stationary footprint. Market entrants leveraging smartphone chassis bypass proprietary hardware costs, signaling a future where mobility defines competitive edge.

Market Share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Type: Video Leads, Infrared Accelerates

Video units accounted for 52.15% pupillometer market share in 2024, reflecting widespread hospital protocols that require high-frame-rate recordings for medico-legal documentation. Digital infrared devices are gaining at an 8.14% CAGR as sensor fidelity now compensates for iris pigmentation variance.

High-resolution video streams allow frame-by-frame review of constriction dynamics, benefitting teaching hospitals that archive de-identified clips for AI model training. Infrared units excel under ambient-light fluctuations, supporting rural outreach vans where dark room conditions are hard to maintain. Hybrid products combining video and infrared tracking are slated for launch in 2026, aiming to unify best-in-class features while expanding the pupillometer market size across both acute and ambulatory settings.

By Application: Neurology Outpaces Ophthalmology

Ophthalmology sustained 60.39% of 2024 revenue, yet neurology is climbing fastest at 8.47% CAGR as TBI screening protocols standardize objective pupil checks. The pupillometer market size for neurology-specific usage is projected to reach USD 182 million by 2030, underpinned by sports-concussion mandates.

Cardiac ICUs are embedding NPi alerts into code-blue dashboards, letting intensivists track recovery trajectories post-resuscitation. Ophthalmology continues leveraging pupil metrics for glaucoma detection, but integrated AI decision support now shortens chair time by 15%, freeing capacity for higher-margin surgical consults. Cross-disciplinary adoption underscores the expanding clinical canvas for quantitative pupillometry.

Market Share
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End User: Vision Centers Close the Gap

Hospitals led spending with 59.14% in 2024; however, eye clinics and vision centers are adding units at an 8.61% CAGR. Their share of the pupillometer market size is forecast to climb to USD 215 million by 2030 as LASIK volumes rebound.

Retail optical chains pilot kiosk-based pupil exams that funnel glaucoma suspects into affiliated ophthalmology practices, demonstrating new retail–clinical synergies. Teaching hospitals deploy multi-unit fleets covering neuro-trauma, anesthesia, and stroke units, ensuring round-the-clock availability. Meanwhile, military clinics integrate ruggedized models into battlefield telehealth kits, highlighting the technology’s versatility across end-user segments.

Geography Analysis

North America retained 43.18% of global revenue in 2024 as FDA Class I classification minimizes regulatory overhead, accelerating hospital procurement cycles [2]Food & Drug Administration, “Product Classification Database – Pupillometer,” fda.gov. Multi-center trials funded by the National Institutes of Health continue to validate new AI algorithms, reinforcing payer confidence. Collegiate athletics increasingly require baseline pupil scans, creating incremental device placements outside traditional hospital settings.

Asia-Pacific is set to register the swiftest trajectory at an 8.87% CAGR through 2030. High myopia prevalence and growing neurologic disease burden are compelling governments to subsidize early-detection technologies. Private ophthalmology chains in India and China are bundling pupil analytics with cataract and refractive packages to differentiate service offerings. Domestic startups are also entering the pupillometer market with low-cost smartphone adaptors, intensifying price competition.

Europe continues to capitalize on cohesive regulatory pathways under the Medical Device Regulation, facilitating faster rollouts of digital infrared innovations. Aging demographics drive elevated glaucoma incidence, sustaining device demand across public hospitals and private clinics. Cross-border telemedicine initiatives linking rural Baltic clinics with neuro-ophthalmology hubs in Germany exemplify collaborative deployment models that extend diagnostic reach.

Pupillometer Market
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The pupillometer market is moderately fragmented. NeurOptics, Essilor Instruments, and NIDEK anchor the premium tier through validated algorithms and broad distribution. NeurOptics extended its NPi-300 rollout to 15 countries in 2024, reinforcing clinical brand equity [3]NeurOptics Inc., “NPi-300 Global Launch Press Release,” neuroptics.com . Essilor Instruments leverages its spectacle-lens network to cross-sell digital infrared units into retail optometry. NIDEK bundles pupillometry with auto-ref keratometers, targeting high-volume Asian clinics.

Smartphone-centric entrants are disrupting incumbents by slashing capital outlay to sub-USD 1,000 and offering pay-per-use analytics subscriptions. A leading app developer recently partnered with an EHR vendor to auto-populate NPi scores into patient charts, shortening documentation time by 30%. OEMs respond by unveiling hybrid software-hardware solutions and pursuing CE-marked AI modules that deliver clinician-grade analysis on consumer devices.

Partnerships dominate strategic activity. In 2025, a US hospital network inked a deal with a cloud-AI specialist to link bedside pupillometers to a centralized neuro-dashboard, pooling data from 50 ICUs. Simultaneously, a European defense agency ordered ruggedized units capable of withstanding −20 °C field conditions, underscoring niche-application potential. Patent filings center on gaze-independent pupil tracking and machine-vision algorithms, signaling a pivot toward software-defined differentiation.

Pupillometer Industry Leaders

  1. NeurOptics Inc.

  2. Essilor Group (Essilor Instruments)

  3. NIDEK SA

  4. Reichert Inc.

  5. Konan Medical USA Inc.

  6. *Disclaimer: Major Players sorted in no particular order
Pupillometer Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Recent Industry Developments

  • May 2023: Acep Direct introduced the Digital Pupillometer to help protect opticians and eyeglass wearers while taking in-store measurements.
  • May 2022: NeurOptics Inc. launched the NPi-300 pupillometer across 15 countries, including the United Kingdom, Germany, Australia, and New Zealand.

Table of Contents for Pupillometer Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rise in awareness & technological advances in quantitative pupillometry
    • 4.2.2 Growing prevalence of neuro-critical care & TBI cases
    • 4.2.3 Increasing adoption for glaucoma & refractive-surgery screening
    • 4.2.4 Integration into AI-enabled ophthalmic diagnostics
    • 4.2.5 Expansion of point-of-care & tele-neurology platforms
    • 4.2.6 Use in sports concussion & battlefield triage protocols
  • 4.3 Market Restraints
    • 4.3.1 High acquisition cost & limited reimbursements
    • 4.3.2 Shortage of clinicians trained in neuro-ophthalmic interpretation
    • 4.3.3 Regulatory uncertainty for software-as-medical-device algorithms
    • 4.3.4 Data-privacy concerns over cloud-based pupil recordings
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter’s Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Bargaining Power of Suppliers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Modality
    • 5.1.1 Hand-held Pupillometer
    • 5.1.2 Table-top Pupillometer
    • 5.1.3 Smartphone-based Pupillometer
  • 5.2 By Type
    • 5.2.1 Digital (Infrared) Pupillometer
    • 5.2.2 Video Pupillometer
    • 5.2.3 Photorefractor-based Pupillometer
  • 5.3 By Application
    • 5.3.1 Ophthalmology
    • 5.3.2 Neurology
    • 5.3.3 Other Clinical Applications
  • 5.4 By End User
    • 5.4.1 Hospitals
    • 5.4.2 Eye Clinics & Vision Centers
    • 5.4.3 Others
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East & Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East & Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)
    • 6.3.1 NeurOptics Inc.
    • 6.3.2 Essilor Instruments
    • 6.3.3 Visionix (Luneau Technology)
    • 6.3.4 Advancing Eyecare (US Ophthalmic)
    • 6.3.5 NIDEK Co., Ltd.
    • 6.3.6 HAAG-STREIT Group
    • 6.3.7 Reichert Technologies
    • 6.3.8 Konan Medical
    • 6.3.9 Good-Lite Company
    • 6.3.10 Grobet USA (Vigor Optical)
    • 6.3.11 Plusoptix GmbH
    • 6.3.12 IDMED (NeuroLight)
    • 6.3.13 Righton Instruments
    • 6.3.14 Topcon Corporation
    • 6.3.15 Carl Zeiss Meditec AG
    • 6.3.16 Keeler Ltd.
    • 6.3.17 Medline Industries
    • 6.3.18 BVI Medical
    • 6.3.19 Optomed Plc
    • 6.3.20 Coburn Technologies
    • 6.3.21 Marco Ophthalmic

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-need Assessment

Research Methodology Framework and Report Scope

Market Definitions and Key Coverage

Our study defines the pupillometer market as all regulated, purpose-built devices, table-top, hand-held, and smartphone-integrated systems that use light stimuli and optical sensors to record pupil size or reflex for clinical decision-making across ophthalmology, neurology, critical care, and select field settings.

Scope Exclusion: Disposable PD rulers and consumer mobile apps that lack medical-device clearance are not counted.

Segmentation Overview

  • By Modality
    • Hand-held Pupillometer
    • Table-top Pupillometer
    • Smartphone-based Pupillometer
  • By Type
    • Digital (Infrared) Pupillometer
    • Video Pupillometer
    • Photorefractor-based Pupillometer
  • By Application
    • Ophthalmology
    • Neurology
    • Other Clinical Applications
  • By End User
    • Hospitals
    • Eye Clinics & Vision Centers
    • Others
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of Middle East & Africa
    • South America
      • Brazil
      • Argentina
      • Rest of South America

Detailed Research Methodology and Data Validation

Primary Research

Interviews with neuro-ICU nurses, ophthalmologists, biomedical engineers, and procurement heads across North America, Europe, and Asia provided live insights on unit utilization, upgrade cycles, and regional reimbursement quirks. Short web surveys with device distributors helped validate average selling prices and spot emerging demand pockets.

Desk Research

We started with open datasets from agencies such as the World Health Organization, the CDC's National Hospital Discharge Survey, and the Brain Trauma Foundation, which reveal incidence trends for cataract surgery and traumatic brain injury.

Trade statistics from UN Comtrade and U.S. customs logs clarify the global flow of infrared optics, while FDA 510(k) filings and European CE registries map the active installed base.

Company 10-Ks, academic journals indexed on PubMed, and news archives on Dow Jones Factiva round out price and adoption cues (D&B Hoovers supplements firm-level revenues).

The sources named here illustrate the range; many additional materials were reviewed to cross-check figures and interpretations.

Market-Sizing & Forecasting

A blended top-down and bottom-up model underpins our numbers.

We reconstruct global demand by linking neurological ICU beds, annual cataract procedure counts, and optometry clinic density to typical device penetration rates; these totals are then tested against supplier shipment roll-ups and sample ASP × volume checks before final adjustment.

Key variables like traumatic brain injury admissions, glaucoma prevalence, hospital capital-budget trends, device replacement interval, and ASP erosion feed a multivariate regression that drives the 2025-2030 forecast.

Scenario analysis gauges upside from AI-enabled upgrades and downside from reimbursement delays, filling data gaps where bottom-up inputs are thin.

Data Validation & Update Cycle

Outputs pass a three-layer review: statistical anomaly screens, senior analyst variance checks, and re-contact with select experts when deviations exceed preset bands.

Mordor Intelligence refreshes every twelve months, issuing interim updates if regulatory or recall events materially shift assumptions.

A final pre-publication sweep ensures clients receive the most current view.

Why Mordor's Pupillometer Market Baseline Earns Deep Trust

Published estimates differ because each firm picks its own device mix, price curve, and refresh rhythm.

Some count basic PD gauges, others roll forward legacy ASPs, and many update only when a press release surfaces.

Key gap drivers include scope creep into non-regulated apps, treating price declines as linear despite tiered discounts, and infrequent verification of installed-base attrition, which our analysts revisit annually through active end-user polling.

Benchmark comparison

Market Size Anonymized source Primary gap driver
USD 453.69 M (2025) Mordor Intelligence -
USD 464.6 M (2024) Global Consultancy A Includes consumer PD tools and applies constant ASP
USD 406.5 M (2024) Trade Journal B Excludes smartphone-linked units sold post-pandemic
USD 480.91 M (2025) Industry Insights C Uses optimistic ICU penetration without device attrition factor

The comparison shows that when scope, price decay, and installed-base churn are aligned, figures converge toward Mordor's balanced baseline.

Our disciplined data checks give decision-makers a figure they can trace, question, and confidently use.

Key Questions Answered in the Report

How big is the Pupillometer Market?

The Pupillometer Market size is expected to reach USD 453.69 million in 2025 and grow at a CAGR of 7.40% to reach USD 648.31 million by 2030.

Which modality is growing fastest?

Hand-held devices post the highest growth at a 7.98% CAGR as emergency medicine, sports clinics, and military units favor portable diagnostics.

Who are the key players in Pupillometer Market?

NeurOptics Inc., Essilor Group (Essilor Instruments), NIDEK SA, Reichert Inc. and Konan Medical USA Inc. are the major companies operating in the Pupillometer Market.

Why is Asia-Pacific the fastest-growing region?

Expanding healthcare infrastructure, high myopia prevalence, and rising neurological disease incidence are propelling an 8.87% CAGR in Asia-Pacific.

Which region has the biggest share in Pupillometer Market?

In 2025, the North America accounts for the largest market share in Pupillometer Market.

What barriers limit wider adoption?

High capital cost, inconsistent reimbursement, and a shortage of clinicians trained in neuro-ophthalmic interpretation remain key obstacles.

Page last updated on:

Pupillometer Report Snapshots